Breast lumps differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 34: | Line 34: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Fibroadenoma]]<ref name="PintoAguiar2014">{{cite journal|last1=Pinto|first1=Joana|last2=Aguiar|first2=Ana Teresa|last3=Duarte|first3=Hálio|last4=Vilaverde|first4=Filipa|last5=Rodrigues|first5=Ângelo|last6=Krug|first6=José Luís|title=Simple and Complex Fibroadenomas|journal=Journal of Ultrasound in Medicine|volume=33|issue=3|year=2014|pages=415–419|issn=02784297|doi=10.7863/ultra.33.3.415}}</ref> | ! align="center" style="background:#DCDCDC;" |[[Fibroadenoma]]<ref name="PintoAguiar2014">{{cite journal|last1=Pinto|first1=Joana|last2=Aguiar|first2=Ana Teresa|last3=Duarte|first3=Hálio|last4=Vilaverde|first4=Filipa|last5=Rodrigues|first5=Ângelo|last6=Krug|first6=José Luís|title=Simple and Complex Fibroadenomas|journal=Journal of Ultrasound in Medicine|volume=33|issue=3|year=2014|pages=415–419|issn=02784297|doi=10.7863/ultra.33.3.415}}</ref> | ||
| align="center" style="background:#F5F5F5;" |Unknown | | align="center" style="background:#F5F5F5;" | | ||
* Unknown | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |Very slight increased risk of [[breast cancer]] in complex [[fibroadenoma]] | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |Most common [[benign]] [[tumor]], women aged 20-30 years | * Very slight increased risk of [[breast cancer]] in complex [[fibroadenoma]] | ||
| align="center" style="background:#F5F5F5;" |Increased in size during [[pregnancy]] or with [[estrogen]] therapy, and regress after [[menopause]] | | align="center" style="background:#F5F5F5;" | | ||
* Most common [[benign]] [[tumor]], women aged 20-30 years | |||
| align="center" style="background:#F5F5F5;" | | |||
* Increased in size during [[pregnancy]] or with [[estrogen]] therapy, and regress after [[menopause]] | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
Line 50: | Line 54: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Proliferative breast lesion without [[atypia]] | | align="center" style="background:#F5F5F5;" | | ||
* Proliferative breast lesion without [[atypia]] | |||
| align="left" style="background:#F5F5F5;" | | | align="left" style="background:#F5F5F5;" | | ||
* Well-defined | * Well-defined | ||
Line 60: | Line 65: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Breast]] [[cyst]]<ref name="pmid16900392">{{cite journal| author=Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V et al.| title=Benign breast diseases. | journal=J Mammary Gland Biol Neoplasia | year= 2005 | volume= 10 | issue= 4 | pages= 325-35 | pmid=16900392 | doi=10.1007/s10911-006-9006-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16900392 }}</ref> | ! align="center" style="background:#DCDCDC;" |[[Breast]] [[cyst]]<ref name="pmid16900392">{{cite journal| author=Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V et al.| title=Benign breast diseases. | journal=J Mammary Gland Biol Neoplasia | year= 2005 | volume= 10 | issue= 4 | pages= 325-35 | pmid=16900392 | doi=10.1007/s10911-006-9006-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16900392 }}</ref> | ||
| align="center" style="background:#F5F5F5;" |[[Hormonal]] fluctuation | | align="center" style="background:#F5F5F5;" | | ||
* [[Hormonal]] fluctuation | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 83: | Line 89: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Nonproliferative breast lesions | | align="center" style="background:#F5F5F5;" | | ||
* Nonproliferative breast lesions | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* simple [[cyst]]: Well circumscribed, posterior acoustic enhancement without internal echoes | * simple [[cyst]]: Well circumscribed, posterior acoustic enhancement without internal echoes | ||
Line 104: | Line 111: | ||
* Unknown prevalence among adolescents | * Unknown prevalence among adolescents | ||
* >50% in women of reproductive age | * >50% in women of reproductive age | ||
| align="center" style="background:#F5F5F5;" |Become present before menses and improve during mensturation | | align="center" style="background:#F5F5F5;" | | ||
* Become present before menses and improve during mensturation | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
Line 125: | Line 133: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Galactocele]]<ref name="pmid18180221">{{cite journal| author=Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P et al.| title=Radiologic evaluation of breast disorders related to pregnancy and lactation. | journal=Radiographics | year= 2007 | volume= 27 Suppl 1 | issue= | pages= S101-24 | pmid=18180221 | doi=10.1148/rg.27si075505 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18180221 }}</ref> | ! align="center" style="background:#DCDCDC;" |[[Galactocele]]<ref name="pmid18180221">{{cite journal| author=Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P et al.| title=Radiologic evaluation of breast disorders related to pregnancy and lactation. | journal=Radiographics | year= 2007 | volume= 27 Suppl 1 | issue= | pages= S101-24 | pmid=18180221 | doi=10.1148/rg.27si075505 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18180221 }}</ref> | ||
| align="center" style="background:#F5F5F5;" |Milk duct [[obstruction]] | | align="center" style="background:#F5F5F5;" | | ||
* Milk duct [[obstruction]] | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |No increased risk of [[malignancy]] | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |Milk retention [[cysts]] with fluid collection among [[pregnant]] women and during [[breast-feeding]] | * No increased risk of [[malignancy]] | ||
| align="center" style="background:#F5F5F5;" |After ending [[lactation]], the [[cysts]] resolve | | align="center" style="background:#F5F5F5;" | | ||
* Milk retention [[cysts]] with fluid collection among [[pregnant]] women and during [[breast-feeding]] | |||
| align="center" style="background:#F5F5F5;" | | |||
* After ending [[lactation]], the [[cysts]] resolve | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
Line 140: | Line 152: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Retention [[cyst]] resulting from lactiferous duct occlusion | | align="center" style="background:#F5F5F5;" | | ||
* Retention [[cyst]] resulting from lactiferous duct occlusion | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Mammography]]: Intermediate mass in absence of classic fat-fluid level | * [[Mammography]]: Intermediate mass in absence of classic fat-fluid level | ||
Line 173: | Line 186: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Hemangioma|Hamartoma]]<ref name="pmid12461066">{{cite journal| author=Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC et al.| title=Hamartoma of the breast: a clinicopathological review. | journal=J Clin Pathol | year= 2002 | volume= 55 | issue= 12 | pages= 951-4 | pmid=12461066 | doi= | pmc=1769817 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12461066 }}</ref> | ! align="center" style="background:#DCDCDC;" |[[Hemangioma|Hamartoma]]<ref name="pmid12461066">{{cite journal| author=Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC et al.| title=Hamartoma of the breast: a clinicopathological review. | journal=J Clin Pathol | year= 2002 | volume= 55 | issue= 12 | pages= 951-4 | pmid=12461066 | doi= | pmc=1769817 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12461066 }}</ref> | ||
| align="center" style="background:#F5F5F5;" |Unknown | | align="center" style="background:#F5F5F5;" | | ||
* Unknown | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |Coexisting [[malignancy]] can occur | | align="center" style="background:#F5F5F5;" |Coexisting [[malignancy]] can occur | ||
Line 202: | Line 216: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Breast abscess]]<ref name="pmid17639835">{{cite journal| author=Dixon JM| title=Breast abscess. | journal=Br J Hosp Med (Lond) | year= 2007 | volume= 68 | issue= 6 | pages= 315-20 | pmid=17639835 | doi=10.12968/hmed.2007.68.6.23574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17639835 }}</ref> | ! align="center" style="background:#DCDCDC;" |[[Breast abscess]]<ref name="pmid17639835">{{cite journal| author=Dixon JM| title=Breast abscess. | journal=Br J Hosp Med (Lond) | year= 2007 | volume= 68 | issue= 6 | pages= 315-20 | pmid=17639835 | doi=10.12968/hmed.2007.68.6.23574 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17639835 }}</ref> | ||
| align="center" style="background:#F5F5F5;" |[[Complication]] of [[breast]] [[mastitis]] | | align="center" style="background:#F5F5F5;" | | ||
* [[Complication]] of [[breast]] [[mastitis]] | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |No increased risk of [[malignancy]] | | align="center" style="background:#F5F5F5;" | | ||
* No increased risk of [[malignancy]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Complication of lactational [[mastitis]] in 14% of cases | * Complication of lactational [[mastitis]] in 14% of cases | ||
* Common among African American women, heavy smokers , and [[obese]] patients | * Common among African American women, heavy smokers , and [[obese]] patients | ||
| align="center" style="background:#F5F5F5;" |Resolve after drainage/ | | align="center" style="background:#F5F5F5;" | | ||
* Resolve after drainage/ | |||
anti-biotic therapy | * anti-biotic therapy | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
Line 223: | Line 239: | ||
* [[Fever]] | * [[Fever]] | ||
* [[Malaise]] | * [[Malaise]] | ||
| align="center" style="background:#F5F5F5;" |[[Blood culture]] is required in severe [[infection]] | | align="center" style="background:#F5F5F5;" | | ||
* [[Blood culture]] is required in severe [[infection]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Inflammatory]] mass [[Purulent]] material drainage either spontaneously or on [[incision]] | * [[Inflammatory]] mass [[Purulent]] material drainage either spontaneously or on [[incision]] | ||
| align="center" style="background:#F5F5F5;" | Fluid collection | | align="center" style="background:#F5F5F5;" | | ||
* Fluid collection | |||
| align="center" style="background:#F5F5F5;" | [[Ultrasound]] | | align="center" style="background:#F5F5F5;" | | ||
* [[Ultrasound]] | |||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
|- | |- | ||
Line 236: | Line 255: | ||
* [[Infection]] | * [[Infection]] | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |No increased risk of [[malignancy]] | | align="center" style="background:#F5F5F5;" | | ||
* No increased risk of [[malignancy]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Common among lactating women (first three months of [[breast-feeding]]) | * Common among lactating women (first three months of [[breast-feeding]]) | ||
* Periductal [[mastitis]] among smokers and associated with [[squamous]] [[metaplasia]] | * Periductal [[mastitis]] among smokers and associated with [[squamous]] [[metaplasia]] | ||
| align="center" style="background:#F5F5F5;" |Resolve after anti-biotic therapy/ | | align="center" style="background:#F5F5F5;" | | ||
* Resolve after anti-biotic therapy/ | |||
drainage | drainage | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
Line 261: | Line 281: | ||
* Ill-defined area with hyperechogenicity with inflamed fat lobules | * Ill-defined area with hyperechogenicity with inflamed fat lobules | ||
* Skin thickening | * Skin thickening | ||
| align="center" style="background:#F5F5F5;" | [[Ultrasound]] | | align="center" style="background:#F5F5F5;" | | ||
* [[Ultrasound]] | |||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
|- | |- | ||
Line 294: | Line 315: | ||
* Leading cause of cancer death in women 40-49 years old | * Leading cause of cancer death in women 40-49 years old | ||
| align="center" style="background:#F5F5F5;" |Positive [[family history]] | | align="center" style="background:#F5F5F5;" | | ||
* Positive [[family history]] | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
Line 345: | Line 367: | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" |May have normal physical exam | | align="center" style="background:#F5F5F5;" | | ||
* May have normal physical exam | |||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
Line 354: | Line 377: | ||
* Noninvasive [[breast cancer]] | * Noninvasive [[breast cancer]] | ||
* Heterogenous group of [[neoplastic]] lesions | * Heterogenous group of [[neoplastic]] lesions | ||
| align="center" style="background:#F5F5F5;" | Suspicious [[microcalcification]] | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | [[Mammography]] | * Suspicious [[microcalcification]] | ||
| align="center" style="background:#F5F5F5;" | | |||
* [[Mammography]] | |||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]<ref name="pmid23791403">{{cite journal |vauthors=Sue GR, Lannin DR, Killelea B, Chagpar AB |title=Predictors of microinvasion and its prognostic role in ductal carcinoma in situ |journal=Am. J. Surg. |volume=206 |issue=4 |pages=478–81 |date=October 2013 |pmid=23791403 |doi=10.1016/j.amjsurg.2013.01.039 |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |Microinvasive [[breast cancer]]<ref name="pmid23791403">{{cite journal |vauthors=Sue GR, Lannin DR, Killelea B, Chagpar AB |title=Predictors of microinvasion and its prognostic role in ductal carcinoma in situ |journal=Am. J. Surg. |volume=206 |issue=4 |pages=478–81 |date=October 2013 |pmid=23791403 |doi=10.1016/j.amjsurg.2013.01.039 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" |Unknown | | align="center" style="background:#F5F5F5;" | | ||
* Unknown | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
– | – | ||
Line 375: | Line 401: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Solitary | * Solitary | ||
* | * Firm palpable mass | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Associated with high grade [[DCIS]] | | align="center" style="background:#F5F5F5;" | | ||
* Associated with high grade [[DCIS]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* A mass with or without [[calcification]] | * A mass with or without [[calcification]] | ||
Line 402: | Line 429: | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |Well-defined | | align="center" style="background:#F5F5F5;" | | ||
* Well-defined | |||
* Firm mass | |||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
Line 408: | Line 437: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Heterogeneous nonepithelial malignancies from [[connective tissue]] of breast | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |Noncalcified oval mass Indistinct margins | * Heterogeneous nonepithelial malignancies from [[connective tissue]] of breast | ||
| align="center" style="background:#F5F5F5;" | [[Mammography]] | | align="center" style="background:#F5F5F5;" | | ||
* Noncalcified oval mass Indistinct margins | |||
| align="center" style="background:#F5F5F5;" | | |||
* [[Mammography]] | |||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Phyllodes tumor]]<ref name="pmid10776873">{{cite journal |vauthors=Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA |title=Phyllodes tumors of the breast: a review of 32 cases |journal=Am Surg |volume=66 |issue=4 |pages=360–6 |date=April 2000 |pmid=10776873 |doi= |url=}}</ref><ref name="pmid11013364">{{cite journal |vauthors=Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK |title=Primary treatment of cystosarcoma phyllodes of the breast |journal=Cancer |volume=89 |issue=7 |pages=1502–11 |date=October 2000 |pmid=11013364 |doi= |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |[[Phyllodes tumor]]<ref name="pmid10776873">{{cite journal |vauthors=Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA |title=Phyllodes tumors of the breast: a review of 32 cases |journal=Am Surg |volume=66 |issue=4 |pages=360–6 |date=April 2000 |pmid=10776873 |doi= |url=}}</ref><ref name="pmid11013364">{{cite journal |vauthors=Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK |title=Primary treatment of cystosarcoma phyllodes of the breast |journal=Cancer |volume=89 |issue=7 |pages=1502–11 |date=October 2000 |pmid=11013364 |doi= |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" |Unknown | | align="center" style="background:#F5F5F5;" | | ||
* Unknown | |||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" | ± | | align="center" style="background:#F5F5F5;" | ± | ||
| align="center" style="background:#F5F5F5;" |Most common in [[premenopausal]] women (40-50 years) | | align="center" style="background:#F5F5F5;" | | ||
* Most common in [[premenopausal]] women (40-50 years) | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Represent 1% of breast tumors | * Represent 1% of breast tumors | ||
Line 435: | Line 469: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Nonepithelial breast [[neoplasm]] with average size of 5 cm | | align="center" style="background:#F5F5F5;" | | ||
* Nonepithelial breast [[neoplasm]] with average size of 5 cm | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Solid mass | * Solid mass | ||
Line 446: | Line 481: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid10375092">{{cite journal |vauthors=Brogi E, Harris NL |title=Lymphomas of the breast: pathology and clinical behavior |journal=Semin. Oncol. |volume=26 |issue=3 |pages=357–64 |date=June 1999 |pmid=10375092 |doi= |url=}}</ref><ref name="pmid10859001">{{cite journal |vauthors=Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D |title=Primary breast lymphomas--a retrospective analysis of twelve cases |journal=Acta Oncol |volume=39 |issue=2 |pages=135–9 |date=2000 |pmid=10859001 |doi= |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |[[Lymphoma]]<ref name="pmid10375092">{{cite journal |vauthors=Brogi E, Harris NL |title=Lymphomas of the breast: pathology and clinical behavior |journal=Semin. Oncol. |volume=26 |issue=3 |pages=357–64 |date=June 1999 |pmid=10375092 |doi= |url=}}</ref><ref name="pmid10859001">{{cite journal |vauthors=Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D |title=Primary breast lymphomas--a retrospective analysis of twelve cases |journal=Acta Oncol |volume=39 |issue=2 |pages=135–9 |date=2000 |pmid=10859001 |doi= |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" |[[Non-Hodgkin lymphoma]] | | align="center" style="background:#F5F5F5;" | | ||
* [[Non-Hodgkin lymphoma]] | |||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
Line 466: | Line 502: | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Diffuse [[B cell lymphoma]] | * Diffuse [[B cell lymphoma]] | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Nonspecific circumscribed masses | * Nonspecific circumscribed masses | ||
Line 476: | Line 512: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Duct ectasia]]<ref name="pmid6286199">{{cite journal |vauthors=Schwartz GF |title=Benign neoplasms and "inflammations" of the breast |journal=Clin Obstet Gynecol |volume=25 |issue=2 |pages=373–85 |date=June 1982 |pmid=6286199 |doi= |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |[[Duct ectasia]]<ref name="pmid6286199">{{cite journal |vauthors=Schwartz GF |title=Benign neoplasms and "inflammations" of the breast |journal=Clin Obstet Gynecol |volume=25 |issue=2 |pages=373–85 |date=June 1982 |pmid=6286199 |doi= |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" |Unknown | | align="center" style="background:#F5F5F5;" | | ||
* Unknown | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |Common among [[perimenopausal]] women | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" |Usually resolve spontaneously | * Common among [[perimenopausal]] women | ||
| align="center" style="background:#F5F5F5;" | | |||
* Usually resolve spontaneously | |||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" |± | | align="center" style="background:#F5F5F5;" |± | ||
| align="center" style="background:#F5F5F5;" |Usually asymptomatic | | align="center" style="background:#F5F5F5;" | | ||
* Usually asymptomatic | |||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Distention of subareolar ducts | | align="center" style="background:#F5F5F5;" | | ||
* Distention of subareolar ducts | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Dilated milk ducts | * Dilated milk ducts | ||
* Fluid-filled ducts | * Fluid-filled ducts | ||
| align="center" style="background:#F5F5F5;" |[[Ultrasound]] | | align="center" style="background:#F5F5F5;" | | ||
* [[Ultrasound]] | |||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Intraductal [[papilloma]]<ref name="pmid22878621">{{cite journal |vauthors=Wen X, Cheng W |title=Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors |journal=Ann. Surg. Oncol. |volume=20 |issue=1 |pages=94–101 |date=January 2013 |pmid=22878621 |doi=10.1245/s10434-012-2590-1 |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |Intraductal [[papilloma]]<ref name="pmid22878621">{{cite journal |vauthors=Wen X, Cheng W |title=Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors |journal=Ann. Surg. Oncol. |volume=20 |issue=1 |pages=94–101 |date=January 2013 |pmid=22878621 |doi=10.1245/s10434-012-2590-1 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" |Unknown | | align="center" style="background:#F5F5F5;" | | ||
* Unknown | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |Common in women between 35-55 years old | | align="center" style="background:#F5F5F5;" | | ||
* Common in women between 35-55 years old | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Possibly benign ones | * Possibly benign ones | ||
Line 516: | Line 560: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Growth of papillary cell into a lumen | | align="center" style="background:#F5F5F5;" | | ||
* Growth of papillary cell into a lumen | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Well-defined | * Well-defined | ||
* Solid nodule | * Solid nodule | ||
| align="center" style="background:#F5F5F5;" | Core needle [[biopsy]] | | align="center" style="background:#F5F5F5;" | | ||
* Core needle [[biopsy]] | |||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lipoma]]<ref name="pmid16720843">{{cite journal |vauthors=Guray M, Sahin AA |title=Benign breast diseases: classification, diagnosis, and management |journal=Oncologist |volume=11 |issue=5 |pages=435–49 |date=May 2006 |pmid=16720843 |doi=10.1634/theoncologist.11-5-435 |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |[[Lipoma]]<ref name="pmid16720843">{{cite journal |vauthors=Guray M, Sahin AA |title=Benign breast diseases: classification, diagnosis, and management |journal=Oncologist |volume=11 |issue=5 |pages=435–49 |date=May 2006 |pmid=16720843 |doi=10.1634/theoncologist.11-5-435 |url=}}</ref> | ||
| align="center" style="background:#F5F5F5;" |Unknown | | align="center" style="background:#F5F5F5;" | | ||
* Unknown | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |Common between age of 40-60 years old | | align="center" style="background:#F5F5F5;" | | ||
* Common between age of 40-60 years old | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 543: | Line 591: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Solitary tumor of mature fat cells | | align="center" style="background:#F5F5F5;" | | ||
* Solitary tumor of mature fat cells | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Well-Circumscribed | * Well-Circumscribed | ||
Line 553: | Line 602: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Sclerosing adenosis]]<ref name="pmid2804888">{{cite journal| author=Jensen RA, Page DL, Dupont WD, Rogers LW| title=Invasive breast cancer risk in women with sclerosing adenosis. | journal=Cancer | year= 1989 | volume= 64 | issue= 10 | pages= 1977-83 | pmid=2804888 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2804888 }}</ref><ref name="pmid15100339">{{cite journal| author=Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N| title=Lower-category benign breast disease and the risk of invasive breast cancer. | journal=J Natl Cancer Inst | year= 2004 | volume= 96 | issue= 8 | pages= 616-20 | pmid=15100339 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15100339 }}</ref> | ! align="center" style="background:#DCDCDC;" |[[Sclerosing adenosis]]<ref name="pmid2804888">{{cite journal| author=Jensen RA, Page DL, Dupont WD, Rogers LW| title=Invasive breast cancer risk in women with sclerosing adenosis. | journal=Cancer | year= 1989 | volume= 64 | issue= 10 | pages= 1977-83 | pmid=2804888 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2804888 }}</ref><ref name="pmid15100339">{{cite journal| author=Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N| title=Lower-category benign breast disease and the risk of invasive breast cancer. | journal=J Natl Cancer Inst | year= 2004 | volume= 96 | issue= 8 | pages= 616-20 | pmid=15100339 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15100339 }}</ref> | ||
! align="center" style="background:#F5F5F5;" |Unknown | ! align="center" style="background:#F5F5F5;" | | ||
* Unknown | |||
! align="center" style="background:#F5F5F5;" |+ | ! align="center" style="background:#F5F5F5;" |+ | ||
! align="center" style="background:#F5F5F5;" |Small risk of [[malignancy]] | ! align="center" style="background:#F5F5F5;" | | ||
! align="center" style="background:#F5F5F5;" |Result in repeating pain during mensturation | * Small risk of [[malignancy]] | ||
! align="center" style="background:#F5F5F5;" | | |||
* Result in repeating pain during mensturation | |||
! align="center" style="background:#F5F5F5;" | | ! align="center" style="background:#F5F5F5;" | | ||
* May present as a mass or incidental finding on [[mammogram]] | * May present as a mass or incidental finding on [[mammogram]] | ||
Line 572: | Line 624: | ||
! align="center" style="background:#F5F5F5;" |NA | ! align="center" style="background:#F5F5F5;" |NA | ||
! align="center" style="background:#F5F5F5;" |Nl | ! align="center" style="background:#F5F5F5;" |Nl | ||
! align="center" style="background:#F5F5F5;" |Proliferative disease | ! align="center" style="background:#F5F5F5;" | | ||
* Proliferative disease | |||
! align="center" style="background:#F5F5F5;" | | ! align="center" style="background:#F5F5F5;" | | ||
* Well-defined or irregular mass | * Well-defined or irregular mass | ||
* [[Microcalcification]] | * [[Microcalcification]] | ||
! align="center" style="background:#F5F5F5;" |[[Mammography]] | ! align="center" style="background:#F5F5F5;" | | ||
* [[Mammography]] | |||
! align="center" style="background:#F5F5F5;" |NA | ! align="center" style="background:#F5F5F5;" |NA | ||
! align="center" style="background:#F5F5F5;" | | ! align="center" style="background:#F5F5F5;" | | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Pseudoangiomatous stromal hyperplasia<ref name="pmid20103437">{{cite journal| author=Celliers L, Wong DD, Bourke A| title=Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. | journal=Clin Radiol | year= 2010 | volume= 65 | issue= 2 | pages= 145-9 | pmid=20103437 | doi=10.1016/j.crad.2009.10.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20103437 }}</ref><ref name="pmid15454202">{{cite journal| author=Salvador R, Lirola JL, Domínguez R, López M, Risueño N| title=Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients. | journal=Breast | year= 2004 | volume= 13 | issue= 5 | pages= 431-5 | pmid=15454202 | doi=10.1016/j.breast.2003.10.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15454202 }}</ref> | ! align="center" style="background:#DCDCDC;" |Pseudoangiomatous stromal hyperplasia<ref name="pmid20103437">{{cite journal| author=Celliers L, Wong DD, Bourke A| title=Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features. | journal=Clin Radiol | year= 2010 | volume= 65 | issue= 2 | pages= 145-9 | pmid=20103437 | doi=10.1016/j.crad.2009.10.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20103437 }}</ref><ref name="pmid15454202">{{cite journal| author=Salvador R, Lirola JL, Domínguez R, López M, Risueño N| title=Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients. | journal=Breast | year= 2004 | volume= 13 | issue= 5 | pages= 431-5 | pmid=15454202 | doi=10.1016/j.breast.2003.10.011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15454202 }}</ref> | ||
! align="center" style="background:#F5F5F5;" |Unknown | ! align="center" style="background:#F5F5F5;" | | ||
* Unknown | |||
! align="center" style="background:#F5F5F5;" |+ | ! align="center" style="background:#F5F5F5;" |+ | ||
! align="center" style="background:#F5F5F5;" |– | ! align="center" style="background:#F5F5F5;" |– | ||
! align="center" style="background:#F5F5F5;" | Common in reproductive age women | ! align="center" style="background:#F5F5F5;" | | ||
* Common in reproductive age women | |||
! align="center" style="background:#F5F5F5;" | | ! align="center" style="background:#F5F5F5;" | | ||
* [[Benign]] stromal [[proliferation]] | * [[Benign]] stromal [[proliferation]] | ||
Line 628: | Line 684: | ||
! align="center" style="background:#F5F5F5;" |+ | ! align="center" style="background:#F5F5F5;" |+ | ||
! align="center" style="background:#F5F5F5;" |– | ! align="center" style="background:#F5F5F5;" |– | ||
! align="center" style="background:#F5F5F5;" |Thick and tender cord on breast skin | ! align="center" style="background:#F5F5F5;" | | ||
* Thick and tender cord on breast skin | |||
! align="center" style="background:#F5F5F5;" |+ | ! align="center" style="background:#F5F5F5;" |+ | ||
! align="center" style="background:#F5F5F5;" |– | ! align="center" style="background:#F5F5F5;" |– | ||
Line 700: | Line 757: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Gynecomastia]]<ref name="pmid23397020">{{cite journal| author=Draghi F, Tarantino CC, Madonia L, Ferrozzi G| title=Ultrasonography of the male breast. | journal=J Ultrasound | year= 2011 | volume= 14 | issue= 3 | pages= 122-9 | pmid=23397020 | doi=10.1016/j.jus.2011.06.004 | pmc=3558246 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23397020 }}</ref><ref name="pmid17881754">{{cite journal| author=Braunstein GD| title=Clinical practice. Gynecomastia. | journal=N Engl J Med | year= 2007 | volume= 357 | issue= 12 | pages= 1229-37 | pmid=17881754 | doi=10.1056/NEJMcp070677 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17881754 }}</ref> | ! align="center" style="background:#DCDCDC;" |[[Gynecomastia]]<ref name="pmid23397020">{{cite journal| author=Draghi F, Tarantino CC, Madonia L, Ferrozzi G| title=Ultrasonography of the male breast. | journal=J Ultrasound | year= 2011 | volume= 14 | issue= 3 | pages= 122-9 | pmid=23397020 | doi=10.1016/j.jus.2011.06.004 | pmc=3558246 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23397020 }}</ref><ref name="pmid17881754">{{cite journal| author=Braunstein GD| title=Clinical practice. Gynecomastia. | journal=N Engl J Med | year= 2007 | volume= 357 | issue= 12 | pages= 1229-37 | pmid=17881754 | doi=10.1056/NEJMcp070677 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17881754 }}</ref> | ||
| align="center" style="background:#F5F5F5;" |[[Hormonal]] imbalance | | align="center" style="background:#F5F5F5;" | | ||
* [[Hormonal]] imbalance | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |Benign breast tissue swelling among men and boys around [[puberty]] | | align="center" style="background:#F5F5F5;" | | ||
* Benign breast tissue swelling among men and boys around [[puberty]] | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
Line 720: | Line 779: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |[[Glandular]] breast changes | | align="center" style="background:#F5F5F5;" | | ||
* [[Glandular]] breast changes | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Nodular]] pattern | * [[Nodular]] pattern | ||
* Dendritic pattern | * Dendritic pattern | ||
* Diffuse [[glandular]] pattern | * Diffuse [[glandular]] pattern | ||
| align="center" style="background:#F5F5F5;" | [[Ultrasound]] | | align="center" style="background:#F5F5F5;" | | ||
* [[Ultrasound]] | |||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]<ref name="pmid11587103">{{cite journal| author=Lower EE, Hawkins HH, Baughman RP| title=Breast disease in sarcoidosis. | journal=Sarcoidosis Vasc Diffuse Lung Dis | year= 2001 | volume= 18 | issue= 3 | pages= 301-6 | pmid=11587103 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11587103 }}</ref> | ! align="center" style="background:#DCDCDC;" |[[Sarcoidosis]]<ref name="pmid11587103">{{cite journal| author=Lower EE, Hawkins HH, Baughman RP| title=Breast disease in sarcoidosis. | journal=Sarcoidosis Vasc Diffuse Lung Dis | year= 2001 | volume= 18 | issue= 3 | pages= 301-6 | pmid=11587103 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11587103 }}</ref> | ||
| align="center" style="background:#F5F5F5;" |Systemic involvement in [[sarcoidosis]] | | align="center" style="background:#F5F5F5;" | | ||
* Systemic involvement in [[sarcoidosis]] | |||
| align="center" style="background:#F5F5F5;" | + | | align="center" style="background:#F5F5F5;" | + | ||
| align="center" style="background:#F5F5F5;" |– | | align="center" style="background:#F5F5F5;" |– | ||
| align="center" style="background:#F5F5F5;" |Rare in patients with systemic involvement | | align="center" style="background:#F5F5F5;" | | ||
* Rare in patients with systemic involvement | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* [[Benign]] palpable mass | * [[Benign]] palpable mass | ||
Line 746: | Line 809: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |[[Idiopathic]] [[systemic]] [[granulomatous]] disorder | | align="center" style="background:#F5F5F5;" | | ||
* [[Idiopathic]] [[systemic]] [[granulomatous]] disorder | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Irregular, | * Irregular, | ||
* Ill-defined, | * Ill-defined, | ||
* Spiculated solid mass | * Spiculated solid mass | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
[[Biopsy]] | * [[Biopsy]] | ||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
|- | |- | ||
Line 779: | Line 843: | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |Collections of liquefied fat | | align="center" style="background:#F5F5F5;" | | ||
* Collections of liquefied fat | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Collections of liquefied fat | * Collections of liquefied fat | ||
* Oil [[cysts]] | * Oil [[cysts]] | ||
| align="center" style="background:#F5F5F5;" | [[Ultrasound]] | | align="center" style="background:#F5F5F5;" | | ||
* [[Ultrasound]] | |||
| align="center" style="background:#F5F5F5;" | NA | | align="center" style="background:#F5F5F5;" | NA | ||
|} | |} |
Revision as of 17:10, 21 January 2019
Breast lumps Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Breast lumps differential diagnosis On the Web |
American Roentgen Ray Society Images of Breast lumps differential diagnosis |
Risk calculators and risk factors for Breast lumps differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Breast lumps must be differentiated from other diseases such as malignancy, cysts, inflammation and non-inflammatory solid lumps. Breast symptoms such as nipple discharge and mastalgia require assessment as well.
Differentiating Breast lumps from other Diseases
Differential diagnosis of breast lumps include:
Diseases | Etiology | Benign | Malignant | Clinical manifestation | Paraclinical findings | Gold standard diagnosis | Associated findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | Lab findings | Histopathology | Imaging | ||||||||||||
Mass | Mastalgia | Nipple discharge | Breast exam | Skin changes | LAP | Others | ||||||||||||
Fibroadenoma[1] |
|
+ |
|
+ | ± | – |
|
– | – | NA | Nl |
|
|
NA | ||||
Breast cyst[2] |
|
+ |
|
|
|
+ | ± | – |
|
– | – | NA | Nl |
|
NA | |||
Fibrocystic change[3] |
|
+ |
|
|
|
+ | + | ± |
|
– | – | NA | Nl | Nonproliferative breast lesions |
|
NA | ||
Galactocele[4] |
|
+ |
|
|
+ | ± | ± |
|
– | – | NA | Nl |
|
|
NA | |||
Cysts of montgomery[5] | Obstruction of periareolar glands of montgomery | + | No increased risk of malignancy | Most common in age of 10-20 years old |
|
+ | ± | ± |
|
± | – | NA | Nl | Acute inflammation due to obstruction of the Montgomery's gland | Single cystic lesion in retroareolar area | Ultrasound | NA | |
Hamartoma[6] |
|
+ | Coexisting malignancy can occur | Common in women older than 35 years old |
|
± | – | – |
|
± | – | NA | Nl |
|
|
NA | ||
Breast abscess[7] | + |
|
|
+ | + | – |
|
+ | – |
|
|
|
NA | |||||
Mastitis[8][9] | + |
|
|
drainage |
± | + | ± |
|
+ | – | Leukocytosis | Breast parenchyma inflammation: |
|
NA | ||||
Diseases | Etiology | Benign | Malignant | Demography | History | Mass | Pain | Nipple discharge | Breast exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Breast carcinoma[10][11][12] | – | + |
|
|
+ | – | ± |
|
± | ± |
|
Nl |
|
| ||||
Ductal carcinoma in situ (DCIS)[13][14] | – | + |
|
|
± | – | ± |
|
– | – | NA | Nl |
|
|
NA | |||
Microinvasive breast cancer[15] |
|
– |
+ |
|
|
+ | – | ± |
|
– | ± | NA | Nl |
|
|
Mammography | NA | |
Breast sarcoma[16] |
|
– | + |
|
|
+ | – | – |
|
± | – | NA | Nl |
|
|
NA | ||
Phyllodes tumor[17][18] |
|
± | ± |
|
|
± | – | – |
|
– | – | NA | Nl |
|
|
NA | ||
Lymphoma[19][20] | – | + |
|
|
+ | – | – |
|
– | ± | NA | Nl |
|
|
|
NA | ||
Duct ectasia[21] |
|
+ | – |
|
|
± | ± | ± |
|
– | – | NA | Nl |
|
|
NA | ||
Intraductal papilloma[22] |
|
+ | – |
|
+ | ± | ± |
|
– | – | NA | Nl |
|
|
|
NA | ||
Lipoma[23] |
|
+ | – |
|
|
+ | – | – |
|
– | – | NA | Nl |
|
|
NA | ||
Sclerosing adenosis[24][25] |
|
+ |
|
|
|
± | + | – |
|
± | – | NA | Nl |
|
|
NA | ||
Pseudoangiomatous stromal hyperplasia[26][27] |
|
+ | – |
|
|
+ | – | – |
|
– | – | NA | Nl |
|
|
NA | ||
Mondor's disease[28][29] | Complication of: | + | – |
|
+ | + | – |
|
+ | – | NA | Nl | Thrombophlebitis of superficial veins of the breast |
|
|
NA | ||
Diseases | Etiology | Benign | Malignant | Demography | History | Mass | Pain | Nipple discharge | Breast exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Diabetic mastopathy[30] |
|
+ | – |
|
|
+ | – | – |
|
– | – | NA | Nl |
|
|
|
NA | |
Gynecomastia[31][32] |
|
+ | – |
|
|
+ | ± | ± |
|
– | – | NA | Nl |
|
NA | |||
Sarcoidosis[33] |
|
+ | – |
|
|
+ | – | – |
|
– | – | NA | Nl |
|
|
NA | ||
Fat necrosis[34] |
|
+ | – |
|
+ | ± | – |
|
– | – | NA | Nl |
|
|
NA |
References
- ↑ Pinto, Joana; Aguiar, Ana Teresa; Duarte, Hálio; Vilaverde, Filipa; Rodrigues, Ângelo; Krug, José Luís (2014). "Simple and Complex Fibroadenomas". Journal of Ultrasound in Medicine. 33 (3): 415–419. doi:10.7863/ultra.33.3.415. ISSN 0278-4297.
- ↑ Courtillot C, Plu-Bureau G, Binart N, Balleyguier C, Sigal-Zafrani B, Goffin V; et al. (2005). "Benign breast diseases". J Mammary Gland Biol Neoplasia. 10 (4): 325–35. doi:10.1007/s10911-006-9006-4. PMID 16900392.
- ↑ Templeman C, Hertweck SP (2000). "Breast disorders in the pediatric and adolescent patient". Obstet Gynecol Clin North Am. 27 (1): 19–34. PMID 10693180.
- ↑ Sabate JM, Clotet M, Torrubia S, Gomez A, Guerrero R, de las Heras P; et al. (2007). "Radiologic evaluation of breast disorders related to pregnancy and lactation". Radiographics. 27 Suppl 1: S101–24. doi:10.1148/rg.27si075505. PMID 18180221.
- ↑ De Silva NK, Brandt ML (2006). "Disorders of the breast in children and adolescents, Part 2: breast masses". J Pediatr Adolesc Gynecol. 19 (6): 415–8. doi:10.1016/j.jpag.2006.09.002. PMID 17174833.
- ↑ Tse GM, Law BK, Ma TK, Chan AB, Pang LM, Chu WC; et al. (2002). "Hamartoma of the breast: a clinicopathological review". J Clin Pathol. 55 (12): 951–4. PMC 1769817. PMID 12461066.
- ↑ Dixon JM (2007). "Breast abscess". Br J Hosp Med (Lond). 68 (6): 315–20. doi:10.12968/hmed.2007.68.6.23574. PMID 17639835.
- ↑ Dixon JM, Ravisekar O, Chetty U, Anderson TJ (1996). "Periductal mastitis and duct ectasia: different conditions with different aetiologies". Br J Surg. 83 (6): 820–2. PMID 8696751.
- ↑ Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists (2007). "ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects". Obstet Gynecol. 109 (2 Pt 1): 479–80. PMID 17267864.
- ↑ Siegel RL, Miller KD, Jemal A (January 2018). "Cancer statistics, 2018". CA Cancer J Clin. 68 (1): 7–30. doi:10.3322/caac.21442. PMID 29313949.
- ↑ Li CI, Uribe DJ, Daling JR (October 2005). "Clinical characteristics of different histologic types of breast cancer". Br. J. Cancer. 93 (9): 1046–52. doi:10.1038/sj.bjc.6602787. PMC 2361680. PMID 16175185.
- ↑ Parise CA, Bauer KR, Brown MM, Caggiano V (2009). "Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004". Breast J. 15 (6): 593–602. doi:10.1111/j.1524-4741.2009.00822.x. PMID 19764994.
- ↑ Virnig BA, Tuttle TM, Shamliyan T, Kane RL (February 2010). "Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes". J. Natl. Cancer Inst. 102 (3): 170–8. doi:10.1093/jnci/djp482. PMID 20071685.
- ↑ Brinton LA, Sherman ME, Carreon JD, Anderson WF (November 2008). "Recent trends in breast cancer among younger women in the United States". J. Natl. Cancer Inst. 100 (22): 1643–8. doi:10.1093/jnci/djn344. PMC 2720764. PMID 19001605.
- ↑ Sue GR, Lannin DR, Killelea B, Chagpar AB (October 2013). "Predictors of microinvasion and its prognostic role in ductal carcinoma in situ". Am. J. Surg. 206 (4): 478–81. doi:10.1016/j.amjsurg.2013.01.039. PMID 23791403.
- ↑ Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WT (April 2012). "Imaging features of primary breast sarcoma". AJR Am J Roentgenol. 198 (4): W386–93. doi:10.2214/AJR.11.7341. PMID 22451578.
- ↑ Geisler DP, Boyle MJ, Malnar KF, McGee JM, Nolen MC, Fortner SM, Broughan TA (April 2000). "Phyllodes tumors of the breast: a review of 32 cases". Am Surg. 66 (4): 360–6. PMID 10776873.
- ↑ Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KK (October 2000). "Primary treatment of cystosarcoma phyllodes of the breast". Cancer. 89 (7): 1502–11. PMID 11013364.
- ↑ Brogi E, Harris NL (June 1999). "Lymphomas of the breast: pathology and clinical behavior". Semin. Oncol. 26 (3): 357–64. PMID 10375092.
- ↑ Barişta I, Baltali E, Tekuzman G, Kars A, Ruacan S, Ozişik Y, Güler N, Güllü IH, Atahan IL, Firat D (2000). "Primary breast lymphomas--a retrospective analysis of twelve cases". Acta Oncol. 39 (2): 135–9. PMID 10859001.
- ↑ Schwartz GF (June 1982). "Benign neoplasms and "inflammations" of the breast". Clin Obstet Gynecol. 25 (2): 373–85. PMID 6286199.
- ↑ Wen X, Cheng W (January 2013). "Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors". Ann. Surg. Oncol. 20 (1): 94–101. doi:10.1245/s10434-012-2590-1. PMID 22878621.
- ↑ Guray M, Sahin AA (May 2006). "Benign breast diseases: classification, diagnosis, and management". Oncologist. 11 (5): 435–49. doi:10.1634/theoncologist.11-5-435. PMID 16720843.
- ↑ Jensen RA, Page DL, Dupont WD, Rogers LW (1989). "Invasive breast cancer risk in women with sclerosing adenosis". Cancer. 64 (10): 1977–83. PMID 2804888.
- ↑ Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004). "Lower-category benign breast disease and the risk of invasive breast cancer". J Natl Cancer Inst. 96 (8): 616–20. PMID 15100339.
- ↑ Celliers L, Wong DD, Bourke A (2010). "Pseudoangiomatous stromal hyperplasia: a study of the mammographic and sonographic features". Clin Radiol. 65 (2): 145–9. doi:10.1016/j.crad.2009.10.003. PMID 20103437.
- ↑ Salvador R, Lirola JL, Domínguez R, López M, Risueño N (2004). "Pseudo-angiomatous stromal hyperplasia presenting as a breast mass: imaging findings in three patients". Breast. 13 (5): 431–5. doi:10.1016/j.breast.2003.10.011. PMID 15454202.
- ↑ Becker L, McCurdy LI, Taves DH (2001). "Superficial thrombophlebitis of the breast (Mondor's disease)". Can Assoc Radiol J. 52 (3): 193–5. PMID 11436415.
- ↑ Catania S, Zurrida S, Veronesi P, Galimberti V, Bono A, Pluchinotta A (1992). "Mondor's disease and breast cancer". Cancer. 69 (9): 2267–70. PMID 1562972.
- ↑ Kudva YC, Reynolds C, O'Brien T, Powell C, Oberg AL, Crotty TB (2002). ""Diabetic mastopathy," or sclerosing lymphocytic lobulitis, is strongly associated with type 1 diabetes". Diabetes Care. 25 (1): 121–6. PMID 11772912.
- ↑ Draghi F, Tarantino CC, Madonia L, Ferrozzi G (2011). "Ultrasonography of the male breast". J Ultrasound. 14 (3): 122–9. doi:10.1016/j.jus.2011.06.004. PMC 3558246. PMID 23397020.
- ↑ Braunstein GD (2007). "Clinical practice. Gynecomastia". N Engl J Med. 357 (12): 1229–37. doi:10.1056/NEJMcp070677. PMID 17881754.
- ↑ Lower EE, Hawkins HH, Baughman RP (2001). "Breast disease in sarcoidosis". Sarcoidosis Vasc Diffuse Lung Dis. 18 (3): 301–6. PMID 11587103.
- ↑ Soo MS, Kornguth PJ, Hertzberg BS (1998). "Fat necrosis in the breast: sonographic features". Radiology. 206 (1): 261–9. doi:10.1148/radiology.206.1.9423681. PMID 9423681.